Chronic Obstructive Pulmonary Disease (COPD) is now the main cause of disability in developed world. The advance COPD related to increasing breathlessness, disability, and periodic hospitalizations. An aging population world cigarette consumption developing countries expand global impact this condition. disorder associated with leads a decrease physical activity failure functional independence....

conclusions we observed acceptable results regarding both efficacy and safety with 62.5 mg of bosentan, twice daily in this group of patients. further clinical trials investigating pah with lower dosages of bosentan may be warranted. results no adverse drug reaction was observed during the follow-up. clinical worsening occurred in six (14%) patients, at least one year after treatment, two of th...

This review is devoted to the distinct associations of inflammatory bowel diseases (IBD) and chronic liver disorders with chronic airway diseases, namely chronic obstructive pulmonary disease and bronchial asthma, and other chronic respiratory disorders in the adult population. While there is strong evidence for the association of chronic airway diseases with IBD, the data are much weaker for t...

background : there is little evidence about the role of zafirlukast (a highly selective ltd4 antagonist) in chronic obstructive pulmonary disease (copd). the zafirlukast can reduce the need for short-acting rescue β2 agonists, produce fewer exacerbations of asthma and increased quality of life as possible benefits treatment for asthma. the aim of our study was to evaluate the effects of zafirlu...

background: similar to developed countries, aging is increased in india. because of the epidemiology and demographic transition phase, chronic diseases and disabilities along with health costs are increasing day by day. as social factors and chronic diseases are the major reasons for geriatric disability, the present study was done with the following objectives: to assess and compare the socio-...

background: chronic obstructive pulmonary diseases (copd) are planned to rank fifth in burden of disease and third with respect to mortality by 2020. carrying out research regarding different aspects of copd is mentioned as important health priorities by academic institutions and governments. the burden of lung disease (bold) initiative was designed a decade ago to develop robust models that ca...